Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Dec;30(6):853–859. doi: 10.1111/j.1365-2125.1990.tb05451.x

Cutaneous blood flow responses in the forearms of Raynaud's patients induced by local cooling and intradermal injections of CGRP and histamine.

S D Brain 1, R G Petty 1, J D Lewis 1, T J Williams 1
PMCID: PMC1368306  PMID: 2288832

Abstract

1. The cutaneous responses of the forearm to local cold exposure and intradermal injection of CGRP and other vasoactive mediators were compared in primary Raynaud's sufferers and normal volunteers. 2. Skin responses in the forearm were measured in terms of erythema reddening and skin blood flow. Visual responses were recorded by tracing and then area calculated by computerised planimetry. Skin blood flow was measured using a laser Doppler blood flow meter. 3. Cooling (5-6 degrees C for 2 min) of a 1 cm2 area of the forearm caused a localised reactive hyperaemia response in normal volunteers, measured using the last Doppler blood flow meter. The peak response in Raynaud's patients was significantly smaller than that of normal volunteers. 4. The cutaneous responses of Raynaud's patients and normal volunteers to intradermal injections of CGRP, histamine and PGE2 were not significantly different. 5. The results suggest that Raynaud's sufferers do not exhibit a diminished response to CGRP in the cutaneous microvasculature and can respond normally to histamine with an axon reflex mediated flare.

Full text

PDF
853

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand P., Bloom S. R., McGregor G. P. Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin. Br J Pharmacol. 1983 Apr;78(4):665–669. doi: 10.1111/j.1476-5381.1983.tb09418.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belch J. J., Newman P., Drury J. K., McKenzie F., Capell H., Leiberman P., Forbes C. D., Prentice C. R. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial. Lancet. 1983 Feb 12;1(8320):313–315. doi: 10.1016/s0140-6736(83)91624-0. [DOI] [PubMed] [Google Scholar]
  3. Brain S. D., Williams T. J. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature. 1988 Sep 1;335(6185):73–75. doi: 10.1038/335073a0. [DOI] [PubMed] [Google Scholar]
  4. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  5. Foreman J. C., Jordan C. C., Oehme P., Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol. 1983 Feb;335:449–465. doi: 10.1113/jphysiol.1983.sp014543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gibbins I. L., Wattchow D., Coventry B. Two immunohistochemically identified populations of calcitonin gene-related peptide (CGRP)-immunoreactive axons in human skin. Brain Res. 1987 Jun 23;414(1):143–148. doi: 10.1016/0006-8993(87)91335-7. [DOI] [PubMed] [Google Scholar]
  7. Holloway G. A., Jr, Watkins D. W. Laser Doppler measurement of cutaneous blood flow. J Invest Dermatol. 1977 Sep;69(3):306–309. doi: 10.1111/1523-1747.ep12507665. [DOI] [PubMed] [Google Scholar]
  8. Lafferty K., De Trafford J. C., Roberts V. C., Cotton L. T. On the nature of Raynaud's phenomenon: the role of histamine. Lancet. 1983 Aug 6;2(8345):313–315. doi: 10.1016/s0140-6736(83)90292-1. [DOI] [PubMed] [Google Scholar]
  9. Mahler F., Saner H., Boss C., Annaheim M. Local cold exposure test for capillaroscopic examination of patients with Raynaud's syndrome. Microvasc Res. 1987 May;33(3):422–427. doi: 10.1016/0026-2862(87)90033-1. [DOI] [PubMed] [Google Scholar]
  10. McEwan J. R., Benjamin N., Larkin S., Fuller R. W., Dollery C. T., MacIntyre I. Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation. 1988 May;77(5):1072–1080. doi: 10.1161/01.cir.77.5.1072. [DOI] [PubMed] [Google Scholar]
  11. Piotrowski W., Foreman J. C. Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol. 1986 Jan;114(1):37–46. doi: 10.1111/j.1365-2133.1986.tb02777.x. [DOI] [PubMed] [Google Scholar]
  12. Thom S. M., Hughes A. D., Goldberg P., Martin G., Schachter M., Sever P. S. The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro. Br J Clin Pharmacol. 1987 Aug;24(2):139–144. doi: 10.1111/j.1365-2125.1987.tb03154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Weihe E., Hartschuh W. Multiple peptides in cutaneous nerves: regulators under physiological conditions and a pathogenetic role in skin disease? Semin Dermatol. 1988 Dec;7(4):284–300. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES